Featured Research

from universities, journals, and other organizations

First near-total face and upper-jaw transplant appears successful

Date:
November 17, 2009
Source:
JAMA and Archives Journals
Summary:
More than a year and a half following the first near-total face and upper jaw transplant, the donor tissue appears successfully integrated, according to a report. The recipient has experienced no long-term rejection, and has regained some functional abilities, including her senses of smell and taste.

More than a year and a half following the first near-total face and upper jaw transplant, the donor tissue appears successfully integrated, according to a report in the November/December issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals. The recipient has experienced no long-term rejection and has regained some functional abilities, including her senses of smell and taste.

Three previous facial transplants were completed prior to this procedure, performed at Cleveland Clinic in December 2008, according to background information in the article. Unlike these, the current procedure was performed on a patient who had already undergone 23 major reconstructive procedures following a gunshot wound to the face. The extensive damage from postoperative scarring and depletion of blood vessels added a complexity to this surgery.

Therefore, a complete vascular workup of the recipient (a 46-year-old woman) was completed before the procedure, report Daniel S. Alam, M.D, and colleagues at Cleveland Clinic, Ohio. A computed tomographic angiogram of the patient's neck was performed to determine which arteries were intact and which were damaged and could not be used to supply blood to donor tissue. These vascular considerations and other anatomical characteristics of the recipient -- for instance, that she had no nasal septum or structure, and no upper jaw -- guided the surgeons' plan for removing the donor facial tissue.

Initially, it was unclear whether the entire donor tissue (including the upper jaw) could be supplied with blood through only facial arteries, as this approach has not previously been described. However, the microscopic intersections of blood vessels in the jaw made it difficult for the surgeons to dissect and connect them. The authors report that due to the bleeding from the donor tissue during surgery, they were confident that the blood supply from the facial arterial system was more than sufficient.

The procedure involved transferring bone and ligaments so that the patient would not experience facial paralysis in the future and would also not require further procedures to elevate facial tissues. As of July 2009, the patient had experienced no surgical complications, has tolerated the immunosuppressive therapy required to keep her body from rejecting the transplant and has obtained significant functional benefits. She can breathe through her nose, eat by mouth and has had significant improvement in her speech. "Sensory and motor recovery is progressing appropriately but will require time to further evaluate final outcomes," the authors write.

An additional procedure to remove extra glandular tissue was planned for late 2009, after the patient regains function of the facial nerve.

The successful procedure raises the possibility that future transplants with such large areas of tissue are possible, the authors note. "On the basis of our findings, we believe this may be feasible with the facial arterial arcade [blood vessel system] alone," they conclude. "While this is a notable distinction, it may not be the clinically most important one. Unlike the other transplants performed to this point, this patient had undergone multiple failed prior reconstructions and had significant recipient vascular depletion. This raises the important potential role of facial transplant as a salvage procedure in cases in which other operations are unavailable and/or suboptimal."

"As with any novel surgical innovation, information gathered in the nascent stages of the procedure will be vital to define the indications and appropriate patient selection," they conclude. "Our findings will hopefully contribute to this active discussion."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Daniel S. Alam; Frank Papay; Risal Djohan; Steven Bernard; Robert Lohman; Chad R. Gordon; Mark Hendrickson; Maria Siemionow. The Technical and Anatomical Aspects of the World's First Near-Total Human Face and Maxilla Transplant. Arch Facial Plast Surg, 2009; 11 (6): 369-377 [link]

Cite This Page:

JAMA and Archives Journals. "First near-total face and upper-jaw transplant appears successful." ScienceDaily. ScienceDaily, 17 November 2009. <www.sciencedaily.com/releases/2009/11/091116163222.htm>.
JAMA and Archives Journals. (2009, November 17). First near-total face and upper-jaw transplant appears successful. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/11/091116163222.htm
JAMA and Archives Journals. "First near-total face and upper-jaw transplant appears successful." ScienceDaily. www.sciencedaily.com/releases/2009/11/091116163222.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins